It’s confusing, and it’s problematic for the industry as a whole
Wednesday, the Tax Court issued its opinion in Alterman v. Commissioner, T.C. Memo 2018-83. This case involved the operation of a medical marijuana dispensary which was reported on Schedule C. The opinion includes a long recitation of intricate accounting details that I will address on a summary basis so as to not lose readers other than accountants. Readers interested in the details should read the opinion linked above.
The important facts are as follows:
- The taxpayer sold marijuana and non-marijuana products. The sales of non-marijuana products were 1.4% of gross receipts in 2010 and 3.5% of gross receipts in 2011.
- On the tax returns, the taxpayer reduced gross receipts by cost of goods sold. The taxpayer also deducted business expenses. It does not appear based on the findings of fact that on the original return the taxpayer disallowed any expenses pursuant to Section 280E.
- It appears the amount of cost of goods sold claimed on the return was, for the most part, amounts paid for purchases of inventory and did not include production costs. At trial, the taxpayer asserted that it incurred over $100,000 of production costs each year in addition to the amounts paid for purchases of inventory.
To Read The Rest Of This Article On Fox Rothschild, Click Here